Vaccine Therapies for Prostate Cancer: Current Status and Future Outlook

被引：1

作者：

Zhou, Wenhao ^{[1
]}

Lu, Xiaojun ^{[1
]}

Tian, Feng ^{[2
]}

Luo, Qianming ^{[3
]}

Zhou, Weihang ^{[3
]}

Yang, Siyuan ^{[3
]}

Li, Wenxuan ^{[4
]}

Yang, Yongjun ^{[4
]}

Shi, Minfeng ^{[5
]}

Zhou, Tie ^{[1
]}

机构：

[1] Tongji Univ, Shanghai Peoples Hosp 4, Sch Med, Dept Urol, Shanghai 200434, Peoples R China

[2] Shanghai Eighth Peoples Hosp, Dept Urol, Shanghai 200235, Peoples R China

[3] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China

[4] Naval Med Univ, Coll Clin Med, Shanghai 200433, Peoples R China

[5] Naval Med Univ, Changhai Hosp, Reprod Ctr, Shanghai 200433, Peoples R China

来源：

VACCINES | 2024年 / 12卷 / 12期

关键词：

prostate cancer; cancer vaccines; immunotherapy; combination therapies; PERSONALIZED PEPTIDE VACCINATION; ANDROGEN DEPRIVATION THERAPY; PHASE I/II TRIAL; SIPULEUCEL-T; CELLULAR IMMUNOTHERAPY; IMMUNOLOGICAL EFFICACY; CLINICAL-TRIAL; DNA VACCINES; II TRIAL; ANTIGEN;

D O I：

10.3390/vaccines12121384

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Prostate cancer is a prevalent cancer in elderly men, and immunotherapy has emerged as a promising treatment approach in recent years. The aim of immunotherapy is to stimulate the body's immune system to target and destroy cancer cells. Cancer vaccines that are highly specific, safe, and capable of creating long-lasting immune responses are a key focus in cancer immunotherapy research. Despite progress in clinical trials showing positive results, the practical use of cancer vaccines still encounters various obstacles. The complexity of the immune microenvironment and variations in the immune systems of individual patients have hindered the progress of research on prostate cancer vaccines. This review examines the history and mechanisms of cancer vaccines, summarizes recent clinical research findings, and explores future directions in the development of prostate cancer vaccines.

引用

页数：15

共 50 条

[21] Graphene in Electronics: Current Status and Future Outlook
Suemitsu, Maki
IDW'11: PROCEEDINGS OF THE 18TH INTERNATIONAL DISPLAY WORKSHOPS, VOLS 1-3, 2011, : 15 - 18
[22] Pharmacogenomics of Methotrexate: Current Status and Future Outlook
Cao, Mengda
Guo, Miao
Wu, De-Qin
Meng, Ling
CURRENT DRUG METABOLISM, 2018, 19 (14) : 1182 - 1187
[23] Adaptive designs: current status, future outlook
Andy Grieve
Trials, 12 (Suppl 1)
[24] Laser peening: Current status and future outlook
Lahrman, DF
Tenaglia, RD
Clauer, AH
SURFACE MODIFICATION TECHNOLOGIES XV, 2002, : 161 - 171
[25] Orthobiologics: Current Status in 2023 and Future Outlook
Rodeo, Scott A.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS, 2023, 31 (12) : 604 - 613
[26] The status of cancer vaccine therapies in urology
Rodriguez, Ronald
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (05) : 412 - 412
[27] Hot Topic: Targeted Cancer Therapies: Current Status and Future Directions
Starakis, Ioannis
CURRENT MEDICINAL CHEMISTRY, 2011, 18 (11) : 1573 - 1574
[28] Current status and future prospects for anti-angiogenic therapies in cancer
Staton, Carolyn A.
Brown, Nicola J.
Reed, Malcolm W. R.
EXPERT OPINION ON DRUG DISCOVERY, 2009, 4 (09) : 961 - 979
[29] Radioimmunotherapy for Prostate Cancer-Current Status and Future Possibilities
Evans-Axelsson, Susan
Timmermand, Oskar Vilhelmsson
Bjartell, Anders
Strand, Sven-Erik
Elgqvist, Jorgen
SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (02) : 165 - 179
[30] Gene therapy for prostate cancer: Current status and future prospects
Harrington, KJ
Spitzweg, C
Bateman, AR
Morris, JC
Vile, RG
JOURNAL OF UROLOGY, 2001, 166 (04): : 1220 - 1233

← 1 2 3 4 5 →